Total Payments
$1.4M
2024 Payments
$277,347
Companies
29
Transactions
3,013
Medicare Patients
920
Medicare Billing
$139,374
Payment Breakdown by Category
Other$1.1M (75.5%)
Travel$223,564 (16.0%)
Consulting$68,094 (4.9%)
Food & Beverage$49,233 (3.5%)
Education$185.17 (0.0%)
Gifts$12.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 387 | 75.3% |
| Travel and Lodging | $223,564 | 1,327 | 16.0% |
| Consulting Fee | $68,094 | 26 | 4.9% |
| Food and Beverage | $49,233 | 1,266 | 3.5% |
| Honoraria | $2,750 | 1 | 0.2% |
| Education | $185.17 | 5 | 0.0% |
| Gift | $12.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $717,628 | 1,075 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $176,917 | 521 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $127,640 | 296 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $95,523 | 192 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $85,185 | 251 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $61,086 | 49 | $0 (2024) |
| Axsome Therapeutics, Inc. | $39,535 | 58 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $34,848 | 77 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $26,757 | 63 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $9,271 | 25 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277,347 | 536 | Vanda Pharmaceuticals Inc. ($89,102) |
| 2023 | $246,398 | 496 | Alkermes, Inc. ($108,689) |
| 2022 | $174,650 | 360 | Alkermes, Inc. ($129,011) |
| 2021 | $94,276 | 241 | Alkermes, Inc. ($83,138) |
| 2020 | $54,236 | 167 | Alkermes, Inc. ($35,916) |
| 2019 | $163,124 | 342 | Alkermes, Inc. ($115,762) |
| 2018 | $212,736 | 546 | Alkermes, Inc. ($97,193) |
| 2017 | $171,361 | 325 | Alkermes, Inc. ($110,649) |
All Payment Transactions
3,013 individual payment records from CMS Open Payments — Page 1 of 121
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,140.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,564.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $229.06 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $117.06 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $112.00 | General |
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $80.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $53.60 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $7.80 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $1.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $27.78 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $335.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,140.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $485.39 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $466.76 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $194.63 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CNS | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $38.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 170 | 414 | $95,975 | $26,465 |
| 2022 | 2 | 134 | 338 | $70,225 | $21,886 |
| 2021 | 5 | 261 | 845 | $131,125 | $37,471 |
| 2020 | 6 | 355 | 1,198 | $188,000 | $53,553 |
Total Patients
920
Total Services
2,795
Medicare Billing
$139,374
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 343 | $68,600 | $19,574 | 28.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 31 | 31 | $8,525 | $4,327 | 50.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $8,500 | $1,692 | 19.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 23 | $10,350 | $872.39 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 303 | $60,600 | $17,322 | 28.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 35 | 35 | $9,625 | $4,564 | 47.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 108 | 281 | $56,200 | $16,135 | 28.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 49 | 457 | $57,125 | $14,167 | 24.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 48 | 49 | $7,350 | $3,998 | 54.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 44 | 46 | $8,050 | $2,725 | 33.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $2,400 | $444.96 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 313 | $62,600 | $21,286 | 34.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 63 | 645 | $80,625 | $19,172 | 23.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 56 | 59 | $8,850 | $4,310 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 114 | $22,800 | $4,260 | 18.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 51 | 53 | $9,275 | $2,979 | 32.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 14 | 14 | $3,850 | $1,544 | 40.1% |
About Dr. Vikram Mehra, M.D
Dr. Vikram Mehra, M.D is a Psychiatry healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801848957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Mehra, M.D has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $277,347 received in 2024. These payments were reported across 3,013 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M).
As a Medicare-enrolled provider, Mehra has provided services to 920 Medicare beneficiaries, totaling 2,795 services with total Medicare billing of $139,374. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Katy, TX
- Active Since 05/17/2006
- Last Updated 10/24/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801848957
Products in Payments
- ARISTADA (Drug) $311,583
- Aristada 441 mg (Drug) $207,610
- LYBALVI (Drug) $198,203
- LATUDA (Drug) $176,917
- FANAPT (Drug) $95,106
- REXULTI (Drug) $84,403
- AUSTEDO (Drug) $75,573
- Auvelity (Drug) $39,535
- UZEDY (Drug) $30,294
- INGREZZA (Drug) $26,757
- COBENFY (Drug) $26,563
- Qelbree (Drug) $20,482
- Austedo XR (Drug) $19,713
- Trintellix (Drug) $15,928
- QELBREE (Drug) $14,366
- AZSTARYS (Drug) $4,047
- PERSERIS (Drug) $2,507
- ABILIFY MAINTENA (Drug) $1,746
- CAPLYTA (Drug) $1,575
- VRAYLAR (Drug) $1,550
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Katy
Marco Renazco, M.d, M.D
Psychiatry — Payments: $43,373
Psychiatry $43,373
Mr. Rafael Guerrero, M.d, M.D
Psychiatry — Payments: $18,255
Psychiatry $18,255
Dr. Debra Stokan, Md, MD
Psychiatry — Payments: $8,551
Psychiatry $8,551
Ramana Surya, Do, DO
Psychiatry — Payments: $4,382
Psychiatry $4,382
Dr. Farhan Khan, M.d.,M.p.h, M.D.,M.P.H
Psychiatry — Payments: $2,848
Psychiatry $2,848
Nadia Mcfarlane, Md, MD
Psychiatry — Payments: $1,478
Psychiatry $1,478